FILE PHOTO: A doctor prepares a dose of AstraZeneca’s COVID-19 vaccine in his general practice, as the spread of the coronavirus disease (COVID-19) continues, in Vienna, Austria April 30, 2021. REUTERS/Leonhard Foeger

MEXICO CITY (Reuters) – AstraZeneca has confirmed setbacks to production of its COVID-19 vaccines in Latin America, excluding Brazil, but said it will still meet a commitment to deliver 150 million doses to the region this year.

The Anglo-Swedish drugmaker said in a statement shared with Reuters on Friday that lower-than-expected production, shortages of critical supplies and longer periods for regulatory approval had slowed the process.

Reporting by Adriana Barrera; Writing by Stefanie Eschenbacher; Editing by Frank Jack Daniel


Read More

Leave a Reply

Your email address will not be published. Required fields are marked *